Virios Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update

Go back to Virios Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update
(NASDAQ: VIRI) Delayed: 0.16 --0 (-0%)
Previous Close $0.16    52 Week High
Open $0.16    52 Week Low
Day High $0.16    P/E N/A 
Day Low $0.16    EPS
Volume 33,000